Development of a leaflet for shared decision-making in antipsychotic formulation for patients with schizophrenia
East Asian Archives of Psychiatry · 30.06.2026 · 36 (2) · 88
DOI: 10.12809/eaap2642 ↗Kurz gefasst
Fachartikel in der Zeitschrift East Asian Archives of Psychiatry, online erschienen am 30.06.2026. Verfasst von K Sugishita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hospital Pharmaceutics, Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Schizophrenia, Antipsychotic Agents, Decision Making, Shared, Decision Support Techniques. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: To develop a decision-aid leaflet to support decision making on antipsychotic formulation in patients with schizophrenia hospitalised for acute symptoms. METHODS: The decision-aid leaflet was developed in accordance with the International Patient Decision Aids Standards and the Ottawa Personal Decision Guide. Usability and readability assessments were conducted among 16 patients with schizophrenia and 51 psychiatric healthcare professionals. Additionally, shared decision making incorporating the decision-aid leaflet was implemented in three patients with schizophrenia. RESULTS: The decision-aid leaflet met all qualifying and certification criteria, as well as 20 of the 23 quality criteria of the International Patient Decision Aids Standards. All three patients with schizophrenia who underwent the shared decision-making process agreed that the leaflet provided sufficient information to guide their decisions regarding changes in antipsychotic formulations. CONCLUSION: A decision-aid leaflet was developed to support decision-making regarding changes in antipsychotic formulations among patients with schizophrenia hospitalised in an acute-care ward. The leaflet appears feasible for use in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hospital Pharmaceutics, Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Tokyo, Japan.
- Department of Pharmacy, Showa Medical University Karasuyama Hospital, Tokyo, Japan.
- Department of Psychiatry, Showa Medical University School of Medicine, Tokyo, Japan.
- Department of Nursing, Showa Medical University Karasuyama Hospital, Tokyo, Japan.
- Public Interest Incorporated Foundation, Sumiyoshi Kaiseikai, Yamanashi, Japan.
- Psychiatric and Mental Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.
Zitieren
APA
Sugishita, K., Sanada, K., Miyata, K., Yoshio, T., Aoki, Y., Watanabe, K., & Momo, K. (2026). Development of a leaflet for shared decision-making in antipsychotic formulation for patients with schizophrenia. East Asian Archives of Psychiatry, 36(2), 88. https://doi.org/10.12809/eaap2642
Vancouver
Sugishita K, Sanada K, Miyata K, Yoshio T, Aoki Y, Watanabe K, et al. Development of a leaflet for shared decision-making in antipsychotic formulation for patients with schizophrenia. East Asian Archives of Psychiatry. 2026;36(2):88. doi:10.12809/eaap2642
BibTeX
@article{Sugishita2026,
author = {Sugishita, K and Sanada, Kenji and Miyata, K and Yoshio, T and Aoki, Y and Watanabe, K and Momo, K},
title = {Development of a leaflet for shared decision-making in antipsychotic formulation for patients with schizophrenia},
journal = {East Asian Archives of Psychiatry},
year = {2026},
volume = {36},
number = {2},
pages = {88},
doi = {10.12809/eaap2642}
}
EUVIMED